A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Huazhong University of Science and Technology

Status: Completed

Conditions: Hepatic Impairment; Rupture, Spontaneous; Hepatocellular Carcinoma; Rupture Liver

Treatments: Procedure: Liver resection; Other: Transcatheter arterial embolization

Study type: Observational

Funder types: Other

Identifiers

NCT03534843

Chenxp011

Details and patient eligibility

About

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma

Full description

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma. And to determine which is better in predicting long-term survival and short-term survival.

Enrollment: 230 patients

Sex: All

Ages: 15 to 76 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be diagnosed as hepatocellular carcinoma pathologically; had a tumor rupture confirmed by Intraperitoneal exploration or clinical signs and symptoms in combination with imaging examination.

Exclusion criteria

• Be diagnosed as not hepatocellular carcinoma pathologically；had repeated transcatheter arterial chemoembolization(TACE) or a long history (more than 1 year) of cancer treatment; loss of follow up or without complete data.

Trial design

230 participants in 2 patient groups

Surgical treatment

Description:

Patients who received liver resection or palliative surgery, such as microwave coagulation therapy, hepatic artery ligation, or suturing ligation.

Treatment:

Procedure: Liver resection

Non-surgical treatment

Description:

Patients who received transcatheter arterial embolization (or transcatheter arterial chemoembolization) or conservative treatment

Treatment:

Other: Transcatheter arterial embolization